Tin(II) Halide Insertion or Halogen Exchange in the Reactions of Dihaloplatinum(II) Complexes with Tin(II) Halide

Reactions of SnCl₂ with the complexes cis‐[PtCl₂(P₂)] (P₂=dppf (1,1′‐bis(diphenylphosphino)ferrocene), dppp (1,3‐bis(diphenylphosphino)propane=1,1′‐(propane‐1,3‐diyl)bis[1,1‐diphenylphosphine]), dppb (1,4‐bis(diphenylphosphino)butane=1,1′‐(butane‐1,4‐diyl)bis[1,1‐diphenylphosphine]), and dpppe (1,5‐bis(diphenylphosphino)pentane=1,1′‐(pentane‐1,5‐diyl)bis[1,1‐diphenylphosphine])) resulted in the insertion of SnCl₂ into the Pt? Cl bond to afford the cis‐[PtCl(SnCl₃)(P₂)] complexes. However, the reaction of the complexes cis‐[PtCl₂(P₂)] (P₂=dppf, dppm (bis(diphenylphosphino)methane=1,1′‐methylenebis[1,1‐diphenylphosphine]), dppe (1,2‐bis(diphenylphosphino)ethane=1,1′‐(ethane‐1,2‐diyl)bis[1,1‐diphenylphosphine]), dppp, dppb, and dpppe; P=Ph₃P and (MeO)₃P) with SnX₂ (X=Br or I) resulted in the halogen exchange to yield the complexes [PtX₂(P₂)]. In contrast, treatment of cis‐[PtBr₂(dppm)] with SnBr₂ resulted in the insertion of SnBr₂ into the Pt? Br bond to form cis‐[Pt(SnBr₃)₂(dppm)], and this product was in equilibrium with the starting complex cis‐[PtBr₂(dppm)]. Moreover, the reaction of cis‐[PtCl₂(dppb)] with a mixture SnCl₂/SnI₂ in a 2 : 1 mol ratio resulted in the formation of cis‐[PtI₂(dppb)] as a consequence of the selective halogen‐exchange reaction. ³¹P‐NMR Data for all complexes are reported, and a correlation between the chemical shifts and the coupling constants was established for mono‐ and bis(trichlorostannyl)platinum complexes. The effect of the alkane chain length of the ligand and Sn^II halide is described.     

Reactions of platinum complexes with 4,7-phenanthroline: crystal structures of mono- and binuclear platinum(II) complexes containing 4,7-phenanthroline

The reaction of a mixture of cis and trans-[PtCl₂(SMe₂)₂] with 4,7-phen (4,7-phen = 4,7-phenanthroline) in a molar ratio of 1 : 1 or 2 : 1 resulted in the formation of mono and binuclear complexes trans-[PtCl₂(SMe₂)(4,7-phen)] (1) and trans-[Pt₂Cl₄(SMe₂)₂(μ-4,7-phen)] (2), respectively. The products have been fully characterized by elemental analysis, ¹H, ¹³C{¹H}, HHCOSY, HSQC, HMBC, and DEPT-135 NMR spectroscopy. The crystal structure of 1 reveals that platinum has a slightly distorted square planar geometry. Both chlorides are trans with a deviation from linearity 177.66(3)°, while the N–Pt–S angle is 175.53(6)°. Similarly, the reaction of a mixture of cis and trans-[PtBr₂(SMe₂)₂] with 4,7-phen in a 1 : 1 or 2 : 1 mole ratio afforded the mono or binuclear complexes trans-[PtBr₂(SMe₂)(4,7-phen)] (3) and trans-[Pt₂Br₄(SMe₂)₂(μ-4,7-phen)] (4), respectively. The crystal structure of trans-[Pt₂Br₄(SMe₂)₂(μ-4,7-phen)].C₆H₆ reveals that 4,7-phen bridges between two platinum centers in a slightly distorted square planar arrangement of the platinum. In this structure, both bromides are trans, while the PtBr₂(SMe₂) moieties are syn to each other. NMR data of mono and binuclear complexes of platinum 1–4 show that the binuclear complexes exist in solution as a minor product, while the mononuclear complexes are major products.     

Dihaloplatinum(II) complexes having diimine ligands: crystal structure,thermal properties,cytotoxicity effects against breast cancer cells and application as a precursor towards nanoparticles

The reaction of potassium tetrachloroplatinate(II) with dimethylsulfide and a mixture of HBr/KBr affords trans-[PtBr₂(SMe₂)₂]; [PtBr₂(Me₂bpy)] (Me₂bpy = 4,4'-dimethyl-2,2'-bipyridine) was prepared from the reaction of trans-[PtBr₂(SMe₂)₂] with Me₂bpy. The crystal structure of the yellow form of [PtBr₂(bu₂bpy)] (bu₂bpy = 4,4'-di-tert-butyl-2,2'-bipyridine) was determined by X-ray crystallography. The X-ray single-crystal structure determination of complex [PtBr₂(bu₂bpy)] reveals that the platinum adopts a square planar geometry with a twofold axis through the platinum atoms. Thermal properties of the related series of diimine platinum(II) complexes [PtX₂(bu₂bpy)] (X?=?Cl, Br, I) reveal that the thermal stabilities increase [PtI₂(bu₂bpy)]?<?[PtCl₂(bu₂bpy)]?<?[PtBr₂(bu₂bpy)]. [PtBr₂(bpy)] (bpy = 2,2'-bipyridine), [PtBr₂(Me₂bpy)] and [PtX₂(bu₂bpy)] (X?=?Cl, Br, I) were studied by MTT assay against two human breast cancer cell lines of MCF-7 and MDA-MB-468 with [PtCl₂(bu₂bpy)] having a higher cytotoxic effect towards both cancer cell lines, which shows the significant role of the halide and diimine ligand. Semi-spherical Pt(0) nanoparticles (NPCs) were prepared by the simple calcination of [PtX₂(bu₂bpy)] (X?=?Cl, Br, I) at 800?°C in air.     

Insertion of SnCl2 into Pt–Cl bonds: synthesis and characterization of four- and five-coordinate trichlorostannylplatinum(II) complexes

Reaction of platinum(IV) chloride with SnCl₂?·?2H₂O in the presence of [NHR₃]₃Cl (R?=?Me, Et) in 3M hydrochloric acid affords the anionic five-coordinate platinum(II) complexes [NHR₃]₃[Pt(SnCl₃)₅], R?=?Me (1), Et (2), respectively. Moreover, platinum(IV) chloride reacts with SnCl₂?·?2H₂O in the presence of bis(triphenylphosphoranylidene)ammonium chloride in acetone/dichloromethane to form [N(PPh₃)₂]₃[Pt(SnCl₃)₅] (3). In contrast, reaction of an acetone solution of platinum(IV) chloride with SnCl₂?·?2H₂O in the presence of bis(triphenylphosphoranylidene) ammonium chloride resulted in the formation of cis-[N(PPh₃)₂]₂[PtCl₂(SnCl₃)₂] (4). The same products are obtained by using a platinum(II) salt as starting material. Similarly, cis and trans- dichlorobis(diethyl sulfide)platinum(II) reacts with SnCl₂?·?2H₂O in 5M hydrochloric acid to give [PtCl(SEt₂)₃]₃[Pt(SnCl₃)₅] (5) by facile insertion of SnCl₂ into the Pt–Cl bond. However, treatment of an acetone solution of cis- and trans-[PtCl₂(SEt₂)₂] with SnCl₂?·?2H₂O in the presence of a small amount of HCl resulted in the formation of 5, which dissociates in solution to give [PtCl₂(SEt₂)₂]. The complexes have been fully characterized by elemental analysis and multinuclear NMR (¹H,?¹³C,?¹⁹⁵Pt,?¹¹⁹Sn) spectroscopy. A structure determination of crystals grown from a solution of 2 by X-ray diffraction methods shows that platinum adopts a regular trigonal bipyramidal geometry.     

Formation of Platinum–Tin Bond by Tin(II)Chloride Insertion

The first ¹¹⁹Sn NMR evidence for the presence of direct platinum–tin bond in solution has been obtained for PtCl(SnCl₃)(bdpp) complex (bdpp = (2S,4S)-2,4-bis(diphenylphosphino)pentane). Various PtCl₂(L₂) complexes (L₂ = heterobidentate P–P, P–O, P–N, P–S chelating ligands) have been reacted with tin(II)chloride resulting in the formation of the corresponding PtCl(SnCl₃)(L₂) derivatives. Tin(II)chloride has been inserted into the Pt–Cl bond transto the harder donor atom of the L₂ ligand.     

Trans Influence of Triphenylstibine: Crystal Structures of cis‐[PtBr2(SbPh3)2], trans‐[PtBr(Ph)(SbPh3)2], [NMe4][PtBr3(SbPh3)], and cis‐[PtBr2(SbPh3)(PPh3)]

The work reports the unexpected reaction of diphenyldibromo antimonates (III) with PtCl₂ and cis‐[PtCl₂(PPh₃)₂]. The reaction gives triphenylstibine containing Pt^II complexes viz. cis‐[PtBr₂(SbPh₃)₂] ( 1 ), trans‐[[PtBr(Ph)(SbPh₃)₂] ( 2 ), [NMe₄][PtBr₃(SbPh₃)] ( 3 ), and cis‐[PtBr₂(PPh₃)(SbPh₃)] ( 4 ). All the complexes were characterised by elemental analyses, IR, Raman, ¹⁹⁵Pt NMR, FAB mass spectroscopy and X‐ray crystallography. A plausible mechanism via the phenyl migration is proposed for the formation of these complexes. The average Pt–Br distance in 1 is 2.456(2) Å, in 2 2.496 Å(trans to Ph) while in 3 it is 2.476 Å (trans to Sb) implying a comparable trans influence of Ph₃Sb and Ph₃P.     

Synthesis of thecis andtrans isomers oftert-butylaminedichloro-(dimethyl sulphoxide)platinum(II) and X-ray structure analysis of thecis compound

Summary Treatment ofcis-dichlorobis(dimethyl sulphoxide)platinum(II) [1] with an excess oftert-butylamine in MeOH yieldstert-butylamine-trans-dichloro(dimethyl sulphoxide)-platinum(II) [(tr-5)], rather than thecis-diaminechloro-(dimethyl sulphoxide)platinum(II) cation expected by analogy with similar reactions reported in the literature. The correspondingcis isomer [(cis-5)] is prepared from the same reactants (and similarly from K₂PtCl₄ andtert-butylamine) in DMSO medium, in which the initially formedtrans compound partially isomerizes to the thermodynamically favouredcis complex. The molecular structure of (cis-5) is determined by X-ray analysis. The coordination around the Pt atom is square-planar, and the DMSO ligand is S-coordinated. The lengths of the Pt-Cl bondscis andtrans to the DMSO ligand are 2.296(11) and 2.321(10) Å, respectively, and are well within expected ranges. Interatomic distances within the amine and DMSO ligands are normal.     

Electrospray mass spectrometric studies of a potential antitumor drug and its analogous platinum(II) and platinum(IV) complexes with the ethylenediamine-N,N′-di-3-propanoato ligand and its dibutyl ester

Abstract  The electrospray mass spectrometric (ESI–MS) behavior of the complexes trans-dichloro(ethylenediamine-N,N′-di-3-propionato)platinum(IV), trans-dibromo(ethylenediamine-N,N′-di-3-propionato)platinum(IV), dichloro(ethylenediamine-N,N′-di-3-propionic acid)platinum(II), tetrachloro(O,O′-di-n-butyl-ethylenediamine-N,N′-di-3-propanoate)platinum(IV), chlorotribromo(O,O′-di-n-butyl-ethylenediamine-N,N′-di-3-propanoate)platinum(IV), and dichloro(O,O′-di-n-butyl-ethylenediamine-N,N′-di-3-propanoate)platinum(II), with the formulae trans-[PtCl₂(eddp)] (1), trans-[PtBr₂(eddp)] (2), [PtCl₂(H₂eddp)] (3), [PtCl₄(Bu₂eddp)] (4), [PtBr₃Cl(Bu₂eddp)] (5), and [PtCl₂(Bu₂eddp)]·H₂O (6), is reported. The deprotonated molecular ions or halide adducts are usually observed. ESI–MS data demonstrate the usefulness of the method for efficient characterization of metal complexes in solution. Graphical Abstract        

Synthesis and anticancer activity of chalcogenide derivatives and platinum(II) and palladium(II) complexes derived from a polar ferrocene phosphanyl–carboxamide

The polar phosphanyl‐carboxamide, 1′‐(diphenylphosphanyl)‐1‐[N‐(2‐hydroxyethyl)carbamoyl]ferrocene ( 1 ), reacts readily with hydrogen peroxide and elemental sulfur to give the corresponding phosphane‐oxide and phosphane‐sulfide, respectively, and with platinum(II) and palladium(II) precursors to afford various bis(phosphane) complexes [MCl₂( 1 ‐κP)₂] (M = trans‐Pd, trans‐Pt and cis‐Pt). The anticancer activity of the compounds was evaluated in vitro with the complexes showing moderate cytotoxicities towards human ovarian cancer cells. Moreover, the biological activity was found to be strongly influenced by the stereochemistry, with trans‐[PtCl₂( 1 ‐κP)₂] being an order of magnitude more active than the corresponding cis isomer. Copyright © 2010 John Wiley & Sons, Ltd.     

Hydrogen‐bonded chains in three cis‐dichloridoplatinum(II) complexes bearing piperidine and amine ligands

The crystal structures of cis‐dichlorido(ethylamine‐κN)(piperidine‐κN)platinum(II), [PtCl₂(C₂H₇N)(C₅H₁₁N)], (I), cis‐dichlorido(3‐methoxyaniline‐κN)(piperidine‐κN)platinum(II), [PtCl₂(C₅H₁₁N)(C₇H₉NO)], (II), and cis‐dichlorido(piperidine‐κN)(quinoline‐κN)platinum(II), [PtCl₂(C₅H₁₁N)(C₉H₇N)], (III), have been determined at 100 K in order to verify the influence of the nonpiperidine ligand on the geometry and crystal packing. The crystal packing is characterized by N—H...Cl hydrogen bonding, resulting in the formation of chains of molecules connected in a head‐to‐tail fashion. Hydrogen‐bonding interactions play a major role in the packing of (I), where the chains further aggregate into planes, but less so in the case of (II) and (III), where π–π stacking interactions are of greater importance.     

Mono- and dinuclear metallacyclic complexes of Pt(II) synthesized from some eugenol derivatives

The complexes K[PtCl₃(Meug)] (1; Meug = methyleugenol), K[PtCl₃(Meteug)] (2; Meteug = methyl eugenoxyacetate), and K[PtCl₃(Eteug)] (3; Eteug = ethyl eugenoxyacetate) reacted with AgNO₃, SnCl₂, KOH, or ethanol–water solutions to lose one aryl proton and form dinuclear metallacyclic complexes Pt₂Cl₂(Meug-1H)₂ (4), Pt₂Cl₂(Meteug-1H)₂ (5), and Pt₂Cl₂(Eteug-1H)₂ (6), respectively. Complexes 4–6 reacted with aliphatic, aromatic, and heterocyclic amines to give various mononuclear metallacyclic platinum complexes 7–15. ¹H NMR spectra showed that in 4–15 Meug, Meteug, and Eteug are bound with Pt(II) both at the benzene carbon and at the ethylenic double bond of the side chain. NOESY spectra and single-crystal X-ray diffraction indicated that in 7–15 the amines are in cis-position with respect to the ethylenic double bond.     

Cis‐ and trans‐influences in [PtCl2(SPh2)2]

Both cis‐ and trans‐di­chloro­bis­(di­phenyl ­sulfide)­platinum(II), [PtCl₂(C₁₂H₁₀S)₂], crystallize as mononuclear pseudo‐square‐planar complexes. In the cis compound, the Pt—Cl distances are 2.295 (2) and 2.319 (2) Å, and the Pt—S distances are 2.280 (2) and 2.283 (2) Å. In the trans compound, Pt is located on a centre of inversion and the Pt—Cl and Pt—S distances are 2.2786 (15) and 2.3002 (12) Å, respectively.     

Complexes of substituted dipyridylpyridazines with palladium(II) and platinum(II)

Reactions of 3,6-bis(2′-pyridyl)pyridazine derivatives (n-dppn)¶ ¶For the n-dppn ligands, n stands for the size of the cyclic aliphatic ring on positions 4 and 5 of the pyridazine ring, n?=?5, 6, 8, and 12. with MX₂(PhCN)₂ (M?=?Pd, Pt; X?=?Cl,?Br) have been investigated. The new complexes cis-[PdCl₂(n-dppn)] (n?=?5,?6,?8,?12), cis-[PtCl₂(n-dppn)]?·?H₂O (n?=?5,?6), cis-[PtCl₂(8-dppn)] and cis-[PtBr₂(5-dppn)] have been characterized by elemental analyses, conductivity measurements, infrared, electronic and ¹H-NMR spectra.     

Synthesis and structure of platinum complexes [Ph4P]+[PtCl3(DMSO)]− and [Ph4P]+[PtCl5(DMSO)]−

The reaction of tetraphenylphosphonium chloride with an equimolar amount of potassium tetrachloroplatinate or hexachloroplatinic acid in dimethyl sulfoxide gave the complexes [Ph₄P]⁺[PtCl₃(DMSO)]^? (I) and [Ph₄P]⁺[PtCl₅(DMSO)]^? (II), respectively. The phosphorus atoms in the cations have tetrahedral environment, the CPC angles and P-C distances 105.63(13)°–112.13(14)°, 1.795(3)–1.797(3) Å I) and 105.7(3)°–112.9(3)°, 1.783(7)–1.791(6) Å II). The platinum coordination polyhedra in the anions [PtCl₃(DMSO)]^? and [PtCl₅(DMSO)]^? are distorted square (Pt-S, 2.1937(8); Pt-Cl, 2.2894(10)–2.3024(10) Å; trans-angles: SPtCl, 177.38(4)°; ClPtCl, 175.40(4)°) and octahedron (Pt-S 2.291(2) Å; Pt-Cl, 2.312(2)–2.334(2) Å, trans-angles: SPtCl, 178.28(9)°; ClPtCl, 178.80(9)° and 178.88(8)°).     

Mixed dimethyl sulfoxide-thiocarbamic ester complexes of platinum(II) halides

Summary The platinum(II) halidecis-[Pt(DMTC)(DMSO)X₂] andcis-[Pt(DETC)(DMSO)X₂](X=Cl or Br; DMSO=dimethyl sulfoxide; DMTC=EtOSCN-Me₂; DETC=EtOSCNEt₂) adducts and the platinum(II) and palladium(II) halide adducts,trans-[M(DETC)₂X₂] (M=Pt or Pd; X=Cl or Br), have been prepared. The complexes were characterized by i.r., and¹H and¹³Cn.m.r. spectroscopy. Both DMTC and DETC coordinate through the sulphur atoms. The 1:2 DETC complexes present the usualtrans configuration, whereas the presence of DMSO favourscis geometry in the mixed species.     

Platinum(II) complexes containing 2-(alkenyl)pyridines

The ligands 2-(allyl)pyridine(APy), and 2-(1-methallyl)pyridine (1-MAPy) react with [Pt₂X₄(PEt₃)₂] (X = Cl or Br), in acetone solution to give complexes of the type [PtX(PEt₃)L] [PtX₃(PEt₃)], (L = APy or 1-MAPy), which contain a bidentate 2-(alkenyl)pyridine, whereas the same reaction in benzene solution gives trans-[PtBr₂(PEt₃)L], (L = APy or 1-MAPy), which contains a monodentate 2-(alkenyl)pyridine; ¹H NMR spectra indicate that both types of product undergo olefin exchange in solution. The same reaction with 2-(3-methallyl)-pyridine [2-(2-butenyl)pyridine] (3-MAPy), 2-(3,3-dimethylallyl)pyridine [2-(3-methyl-2-butenyl)pyridine] (3,3-DMAPy), and 2-(3-butenyl)pyridine (BPy), in either acetone or benzene solution, gives only trans-[PtBr₂(PEt₃)L]. The reaction of trans-[PtBr₂(PEt₃)L] (L = APy or 3-MAPy) with AgClO₄ gives [PtBr(PEt₃)L]ClO₄. Complexes of the type [PtCl₂L], which contain bidentate 2-(alkenyl)pyridines, result on reaction of L = APy, 3-MAPy, 3,3-DMAPy, BPy, MBPy with [Pt₂Cl₄(C₂H₄)₂].     

Heterobimetallic complexes of cis-1,2-bis(diphenylphosphine)ethene containing tin and nickel,palladium or platinum

Summary New heterobimetallic complexes of nickel, palladium or platinum and the ligand cis-1,2-bis(diphenylphosphine)-ethene, dppen, and tin were prepared. The transition metal is bonded either directly or via chlorine bridges to the tin atom. The compounds were obtained from precursor complexes of the general formula [M(dppen)Cl₂] (M = Ni, Pd or Pt) by reaction with Ph₃SnH or SnCl₂.     

Insertion of tin(II) bromide into Pt–X (X = Cl,Br) bond of dimethylplatinum(IV) complexes: A novel polymorphic form of [PtBr2(bpy)]

The platinum(II) complex [PtMe₂(bpy)] (bpy = 2,2′-bipyridine) reacted with a large excess of dihaloalkanes X(CH₂)_nX (n = 1, X = Cl; n = 4, X = Br) to form the platinum(IV) complexes [PtMe₂X{(CH₂)_nX}(bpy)] (n = 1, X = Cl, 1a; n = 4, X = Br, 1b). The reaction of complexes 1a and 1b with SnBr₂ resulted in insertion of SnBr₂ into Pt–X (X = Cl, Br) bond to afford the trihalostannyl complexes [PtMe₂(SnBr₂X){(CH₂)_nX}(bpy)] (n = 1, X = Cl, 2a; n = 4, X = Br, 2b). The synthesis of such trihalostannylplatinum(IV) complexes is reported for the first time. The complex 2a was decomposed in CH₂Cl₂ solution and single crystals of [PtBr₂(bpy)] (3a) were obtained. The X-ray structure determination of 3a revealed a new polymorphic form of [PtBr₂(bpy)]. The molecules undergo a remarkable stacking along the b-axis to form a zigzag Pt?Pt?Pt chain containing both short (3.799 Å) and long (5.175 Å) Pt?Pt separations through the crystal. The crystal structure is compared to that of the yellow modification of [PtBr₂(bpy)].     

Kinetic characterization of the interactions of trans-dichloro-platinum(IV) anticancer prodrugs and a model compound with thiosulfate

Sodium thiosulfate has been utilized as a rescuing agent for relief of the toxic effects of cisplatin and carboplatin. In this work, we characterized the kinetics of reactions of the trans-dichloro-platinum(IV) complexes cis-[Pt(NH₃)₂Cl₄], ormaplatin [Pt(dach)Cl₄] and trans-[PtCl₂(CN)₄]^2? (anticancer prodrugs and a model compound) with thiosulfate at biologically important pH. An overall second-order rate law was established for the reduction of trans-[PtCl₂(CN)₄]^2? by thiosulfate, and varying the pH from 4.45 to 7.90 had virtually no influence on the reaction rate. In the reactions of thiosulfate with cis-[Pt(NH₃)₂Cl₄] and with [Pt(dach)Cl₄], the kinetic traces displayed a fast reduction step followed by a slow substitution involving the intermediate Pt(II) complexes. The reduction step also followed second-order kinetics. Reductions of cis-[Pt(NH₃)₂Cl₄] and [Pt(dach)Cl₄] by thiosulfate proceeded with similar rates, presumably due to their similar configurations, whereas the reduction of trans-[PtCl₂(CN)₄]^2? was about 1,000 times faster. A common reduction mechanism is suggested, and the transition state for the rate-determining step has been delineated. The activation parameters are consistent with transfer of Cl⁺ from the platinum(IV) center to the attacking thiosulfate in the rate-determining step.     

The Synthesis by Decarboxylation Reactions and Crystal Structures of 1, n–Bis(diphenylphosphino)alkane(pentafluorophenyl)‐platinum(II) Complexes

Decarboxylation reactions between the complexes cis–[PtCl₂L] (L = 1, n–bis(diphenylphosphino)–ethane (n = 2, dppe), –propane (n = 3, dppp) or –butane (n = 4, dppb)) and thallium(I) pentafluorobenzoate in pyridine give cis–[PtCl(C₆F₅)L] and cis–[Pt(C₆F₅)₂L] complexes in high yields with short reaction times. X–ray crystal structures of cis–[PtCl(C₆F₅)(dppe)] · 0.5 C₅H₅N, cis–[PtCl(C₆F₅)(dppp)], cis–[PtCl(C₆F₅)(dppb)] · C₃H₆O, cis–[Pt(C₆F₅)₂L] (L = dppe, dppp and dppb) and the reactants cis–[PtCl₂(dppp)] (as a CH₂Cl₂ solvate) and cis–[PtCl₂(dppb)] show monomeric structures with chelating diphosphine ligands in all cases rather than dimers with bridging diphosphines. ³¹P NMR data are consistent with these structures in solution.